Jan 28, 2022
The importance of patient perspectives, ie, the behaviors, concerns, and experiences of patients with rheumatic conditions, and patient-reported outcomes, were highlighted through several studies presented at the American College of Rheumatology (ACR) Convergence 2021.
In this episode, Shilpa Venkatachalam, PhD, MPH,...
Jan 13, 2022
The American College of Rheumatology (ACR) Convergence held in November 2021 included several important abstracts and sessions in gout research.
In this episode, Ada Kumar, MD, of Horizon Therapeutics, and Suneet Grewal, MD, of East Bay Rheumatology Medical Group, provide an overview of the compelling news and research...
Dec 9, 2021
There were some exciting and clinically meaningful research in scleroderma/systemic sclerosis presented by experts at the American College of Rheumatology (ACR) Convergence 2021.
Tracy Frech, MD, provides a comprehensive overview of the studies presented at the ACR meeting this year, by categorizing them into 5...
Nov 12, 2021
Stay tuned for season 2 of the Rheum Advisor on Air podcast!
Sep 9, 2021
The recent US Food and Drug Administration (FDA) approval of anifrolumab for the treatment of systemic lupus erythematosus (SLE) came a decade after the approval of human monoclonal antibody belimumab.
In this episode of the Rheumatology Advisor podcast, we speak with Mary K. Crow, MD, who provides a deeper insight into...